FDA Inspection 1124289 — Bioverativ USA Inc
The FDA completed an inspection of Bioverativ USA Inc on June 23, 2020 in Bridgewater, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 23, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Bridgewater, NJ (United States)